Skip to main content
Signal8

Telesis Bio, Inc. (TBIO)

Telesis Bio, Inc., formerly known as Codex DNA, Inc. (and SGI-DNA, Inc. prior to that), is a San Diego, California-based synthetic biology company established in 2011. The company provides a comprehensive suite of instruments, reagents, and services for synthetic biology applications, catering primarily to pharmaceutical and academic laboratories worldwide. Its clientele also extends to government institutions, contract research organizations (CROs), and other synthetic biology enterprises. Among its core offerings is the BioXp system, a groundbreaking platform that empowers researchers to generate endpoint-ready synthetic DNA directly from digital sequences. Complementing this, the BioXp portal offers an intuitive online environment with guided workflows and design tools for constructing new DNA sequences and assembling them into desired vectors. For specific synthetic biology tasks, Telesis Bio supplies BioXp kits, which include essential building blocks and proprietary reagents like its well-known Gibson Assembly products. Additional solutions encompass cloud-based scripts and specialized benchtop reagents designed for post-BioXp system workflows. Through its Biofoundry Services, customers can commission and receive BioXp system-generated products, such as custom genes, clones, cell-free amplified DNA, and diverse variant libraries. The company also performs enzymatic DNA synthesis using short oligo ligation assembly techniques.

Sector: Medical - Devices

Industry: Medical - Devices

Telesis Bio, Inc. logo

Telesis Bio, Inc.

OTC:TBIOHealthcare
+0.00%$0.0100
CLOSED
Mkt Cap$784K
EV-
Float59.35M
O/S78.39M
VOL113 sh
$ Vol$1
RVOL0.20×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Telesis Bio, Inc. logoOTC:TBIOClosed$0.0100+0.00%
Financials Summary
Revenue$27.51M
Net Income-$47.72M
Total Assets$70.41M
Free Cash Flow-$36.65M
Debt & Equity
Debt 37%
Equity 32%
Preferred 31%
Total Debt$34.38M
Total Equity$29.54M
Preferred Stock$29.3M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
  1. 1:18Reverse split
    May 9, 202418 shares → 1
  2. 1:30Reverse split
    Jun 13, 201730 shares → 1
  3. 1:12Reverse split
    Jan 28, 201412 shares → 1
Balance Sheet Details
Assets$70.41M
Liabilities$40.87M
Accounts Receivable$5.99M
Accounts Payable$3.28M
Inventory$4.03M
PP&E (Net)$34.52M
Goodwill$3.5M
Intangible Assets$1.37M
Income Statement
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$27.51M$27.43M$11.04M$6.58M$4.8M$1.42M$0$0
YoY Growth0.3%148.4%67.9%36.9%238.4%---
Cost of Revenue$10.56M$11.84M$6.74M$2.95M$8.89M$0$0$0
Gross Profit$16.95M$15.6M$4.3M$3.63M-$4.08M$1.42M$0$0
Gross Margin61.6%56.8%38.9%55.1%-85.0%100.0%--
Research and Development$17.5M$23.46M$14.55M$8.93M$1.32M$58.02M$47.02M$15.66M
Selling, General, and Administrative$34.6M$38.62M$25.13M$11.06M$1.57M$22.61M$14.31M$11.14M
Other$11.39M$0$300K$0$0$0$0$0
Total Operating Expenses$63.49M$62.08M$39.67M$19.99M$2.89M$80.63M$61.33M$26.8M
Operating Income (EBIT)-$46.54M-$46.48M-$35.37M-$16.36M-$6.98M-$102.96M-$78.92M-$26.7M
Operating Margin-169.2%-169.4%-320.3%-248.8%-145.2%-7250.7%--
Interest Expense$3.1M$1.96M$1.37M$690K$1.49M$0$0$0
Interest Income$1.74M$738K$0$0$1.79M$1.32M$281K$114K
Other Income (Expense)-$1.16M-$1.96M-$3.57M-$1.64M-$1.33M$0$0$0
Income Before Tax (EBT)-$47.7M-$48.45M-$38.94M-$18M-$8.3M-$102.96M-$78.92M-$26.7M
Income Tax Expense$24K$24K$14K$5K$0-$5.57M-$12.48M$0
Net Income-$47.72M-$48.47M-$38.96M-$18.01M-$8.3M-$97.39M-$66.44M-$26.7M
Net Income Margin-173.5%-176.7%-352.8%-273.9%-172.8%-6858.8%--
Supplementary Data
EPS-1.59-1.65-1.33-0.62-0.20-2.16-2.23-0.89
Diluted EPS-1.59-1.65-1.33-0.62-0.20-2.16-2.23-0.89
Weighted Average OS29.93M29.46M29.32M29.23M40.76M45.00M29.86M29.86M
EBITDA-$40.49M-$43.62M-$36M-$15.86M-$5.96M-$100.12M-$77.34M-$25.97M
EBITDA Margin-147.2%-159.0%-326.0%-241.1%-123.9%-7050.6%--
Balance Sheet
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Assets
Current Assets
Cash and Cash Equivalents$1.57M$30.42M$82.81M$13.46M$29.14M$55.2M$48.06M$57.73M
Short-Term Investments$17.59M$13.16M$0$0$0$88.9M$10M$12.99M
Cash and Short-Term Investments$19.16M$43.75M$82.81M$13.46M$29.14M$144.1M$58.05M$70.72M
Accounts Receivable$5.99M$5.85M$3.67M$2.27M$1.49M$0$0$0
Inventory$4.03M$2.2M$2.37M$601K$712K$0$0$0
Other Current Assets$175K$3.29M$4.34M$0$0$5.5M$4.98M$1.72M
Total Current Assets$30.35M$55.09M$93.18M$17.18M$31.43M$149.6M$63.03M$72.44M
Long-Term Assets
Property, Plant & Equipment Net$34.52M$8.52M$5.74M$3.78M$888K$10.24M$6.78M$4.86M
Goodwill$3.5M$14.89M$14.33M$3.5M$3.5M$21.36M$21.36M$21.36M
Intangible Assets$1.37M$1.88M$2.4M$2.33M$2.86M$106.44M$106.84M$106.84M
Long-Term Investments$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0
Other Long-Term Assets$676K$981K$609K$81K$81K$0$533K$65K
Total Long-Term Assets$40.06M$26.27M$23.07M$9.68M$7.33M$138.05M$135.51M$133.13M
Other Assets$0$0$0$0$0$0$0$0
Total Assets$70.41M$81.36M$116.26M$26.86M$38.76M$287.65M$198.55M$205.56M
Liabilities
Current Liabilities
Accounts Payable$3.28M$1.29M$2.5M$1.19M$614K$5.17M$4.59M$462K
Short-Term Debt$0$0$603K$1.33M$530K$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0
Current Unearned Revenue$338K$3.96M$205K$606K$112K$2.57M$0$0
Other Current Liabilities$92K$373K$335K$22K-$530K$6.55M$7.49M$11.55M
Total Current Liabilities$8.18M$13.5M$9.73M$5.63M$1.72M$14.29M$12.09M$12.01M
Long-Term Liabilities
Long-Term Debt$5.27M$19.65M$14.09M$3.35M$4.47M-$34.58M$0$0
Long-Term Unearned Revenue$95K$142K$150K$40K$33K$41.84M$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$481K$6.04M$18.52M
Other Long-Term Liabilities$36K$367K$108K$40.45M$39.88M$140.33M$273.94M$213.63M
Total Long-Term Liabilities$32.69M$21.3M$15.74M$46.7M$44.54M$148.07M$279.98M$232.15M
Other Liabilities$0$0$0$0$0$0$0$0
Total Liabilities$40.87M$34.8M$25.47M$52.32M$46.26M$162.36M$292.06M$244.15M
Stockholders' Equity
Preferred Stock$29.3M$0$0$38.91M$38.91M$0$0$0
Common Stock$5K$5K$5K$2K$2K$45K$10K$9K
Retained Earnings-$161.47M-$113.74M-$65.27M-$26.31M-$8.3M-$246.2M-$148.81M-$82.36M
Comprehensive Income & Other$0-$3K$0-$38.91M-$38.91M$196K$79K$0
Other Stockholders' Equity$191M$160.3M$156.05M$851K$797K$371.45M$55.28M$43.77M
Total Equity$29.54M$46.56M$90.78M-$25.46M-$7.5M$125.3M-$93.52M-$38.59M
Minority Interest$0$0$0$0$0$0$0$0
Total Liabilities and Equity$70.41M$81.36M$116.26M$26.86M$38.76M$287.65M$198.55M$205.56M
Supplementary Data
Total Debt$34.38M$21.43M$17.32M$8.33M$4.77M$0$0$0
Net Debt$32.81M-$8.99M-$65.48M-$5.14M-$24.38M-$55.2M-$48.06M-$57.73M
Cash Flow Statement
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating Activities
Net Income-$47.72M-$48.47M-$38.96M-$18.01M-$8.3M-$97.39M-$66.44M-$26.7M
Depreciation & Amortization$4.1M$2.88M$1.57M$1.46M$857K$2.84M$1.58M$730K
Deferred Income Tax$0$0$2.3M$443K-$486K-$5.57M-$12.48M$0
Stock-Based Compensation$3.96M$3.73M$1.09M$43K$13K$0$3.68M$686K
Changes in Working Capital:
  Accounts Receivable-$1.33M-$2.19M-$735K-$774K-$859K$0$0$0
  Inventory-$1.82M$168K-$1.46M$111K$723K$0$0$0
  Accounts Payable-$3.29M$1.16M-$298K$142K$232K$658K$4.03M$84K
  Other Working Capital-$1.32M$2.98M-$542K$501K$129K$83.71M-$13.51M$980K
Total Working Capital Change-$7.77M$2.13M-$3.04M-$20K$225K$84.36M-$9.48M$1.06M
Other Non-Cash Items$12.76M$1.02M$333K$706K$1.3M-$13.71M$32.35M$500K
Net Cash from Operating-$34.67M-$38.72M-$36.7M-$15.38M-$6.39M-$22.13M-$50.79M-$23.72M
Investing Activities
Capital Expenditures-$1.98M-$4.47M-$1.85M-$204K-$79K-$6.58M-$2.77M-$862K
Acquisitions$16K-$556K-$13.19M$0$0$0$0$0
Purchases of Investments-$33.77M-$77.43M$0$0-$174.27M-$136.69M-$70.77M-$34.93M
Sales of Investments$30M$64.44M$0$0$159.62M$57.98M$73.84M$41.9M
Other Investing Activities$0$0$0$0$14.65M$0$0$0
Net Cash from Investing-$5.74M-$18.01M-$15.04M-$204K-$79K-$85.29M$304K$6.11M
Financing Activities
Debt Repaid$15.09M-$4.68M-$9.79M$107K----
Common Stock Issuance$26.66M$528K$112.48M$11K$32.95M$117.45M$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0
Other Financing Activities$8.25M-$700K-$1.19M$0$35.11M$113.62M$41.75M$50.75M
Net Cash from Financing$11.56M$4.51M$121.08M-$96K$35.11M$113.62M$41.75M$50.75M
Forex Effect-$3K$0$0$0$669K$0$0$0
Net Change in Cash-$28.85M-$52.21M$69.34M-$15.68M-$27.08M$6.2M-$8.74M$33.14M
Supplementary Data
Operating Cash Flow-$34.67M-$38.72M-$36.7M-$15.38M-$6.39M-$22.13M-$50.79M-$23.72M
Capital Expenditure-$1.98M-$4.47M-$1.85M-$204K-$79K-$6.58M-$2.77M-$862K
Free Cash Flow-$36.65M-$43.18M-$38.55M-$15.59M-$6.47M-$28.71M-$53.56M-$24.58M
Cash at Beginning$30.59M$82.81M$13.46M$29.14M$56.22M$50.02M$58.76M$25.62M
Cash at End$1.75M$30.59M$82.81M$13.46M$29.14M$56.22M$50.02M$58.76M